{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:30:04Z","timestamp":1790199004535,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ejpb.2011.02.014","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T14:17:56Z","timestamp":1298557076000},"page":"499-505","source":"Crossref","is-referenced-by-count":42,"title":["Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: In vitro and in vivo evaluation"],"prefix":"10.1016","volume":"78","author":[{"given":"Ziya","family":"Bayrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cetin","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansel Kose","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Savaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalcin","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2011.02.014_b0005","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1526-4610.2009.01518.x","article-title":"Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies","volume":"49","author":"Hedlund","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.ejpb.2011.02.014_b0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejps.2003.07.002","article-title":"In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance","volume":"20","author":"Bredenberg","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2011.02.014_b0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1208\/s12248-008-9031-x","article-title":"Development of a GC\u2013MS assay for the determination of fentanyl pharmacokinetics in rabbit plasma after sublingual spray delivery","volume":"10","author":"Malkawi","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2011.02.014_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2006.10.012","article-title":"Evaluation of HO-1-u-1 cell line as an in vitro model for sublingual drug delivery involving passive diffusion\u2013initial validation studies","volume":"334","author":"Wang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijpharm.2008.11.010","article-title":"HO-1-u-1 model for screening sublingual drug delivery \u2013 influence of pH, osmolarity and permeation enhancer","volume":"370","author":"Wang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0030","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0142-9612(00)00134-4","article-title":"Enhancing effect of chitosan on peptide drug delivery across buccal mucosa","volume":"21","author":"Senel","year":"2000","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ejpb.2011.02.014_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2.3.507","article-title":"Buccal drug delivery","volume":"2","author":"Smart","year":"2005","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2011.02.014_b0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/03639040500519367","article-title":"Effect of excipient and processing variables on adhesive properties and release profile of pentoxifylline from mucoadhesive tablets","volume":"32","author":"Surapaneni","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2011.02.014_b0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v25.i5.20","article-title":"Sublingual drug delivery","volume":"25","author":"Goswami","year":"2008","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2011.02.014_b0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejps.2009.07.003","article-title":"Preparation of zolmitriptan\u2013chitosan microparticles by spray drying for nasal delivery","volume":"38","author":"Alhalaweh","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.02.014_b0055","series-title":"Pharmaceutical Dosage Forms: Tablets, vol. 1","first-page":"195","article-title":"Compressed tablets by direct compression","author":"Shangraw","year":"1989"},{"issue":"2","key":"10.1016\/j.ejpb.2011.02.014_b0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0250-474X.41452","article-title":"Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants","volume":"70","author":"Setty","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.02.014_b0065","doi-asserted-by":"crossref","unstructured":"N.A. Bhimte, P.T. Tayade, Evaluation of microcrystalline cellulose prepared from sisal fibers as a tablet excipient: a technical note, AAPS Pharm. Sci. Tech. 8(1) (2007) Article 8. doi:10.1208\/pt0801008.","DOI":"10.1208\/pt0801008"},{"issue":"4","key":"10.1016\/j.ejpb.2011.02.014_b0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1248\/cpb.58.443","article-title":"Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion\u2013precipitation method","volume":"58","author":"Randale","year":"2010","journal-title":"Chem. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ejpb.2011.02.014_b0075","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1248\/cpb.56.598","article-title":"Improvement of HPMC tablet disintegration by the addition of inorganic salts","volume":"56","author":"Kajiyama","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2011.02.014_b0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5173(00)00426-9","article-title":"Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC","volume":"202","author":"Ishikawa","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2011.02.014_b0085","first-page":"181","article-title":"Buccal mucoadhesive tablets of flurbiprofen: characterization and optimization","volume":"3","author":"Darwish","year":"2009","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.ejpb.2011.02.014_b0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10717540490280688","article-title":"Development of mucoadhesive dosage forms of buprenorphine for sublingual delivery","volume":"11","author":"Das","year":"2004","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.ejpb.2011.02.014_b0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT100203P6","article-title":"Dissolution testing orally disintegrating tablets","volume":"10","author":"Klancke","year":"2003","journal-title":"Diss. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2011.02.014_b0100","first-page":"76","article-title":"A review of co-processed directly compressible excipients","volume":"8","author":"Gohel","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2011.02.014_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt050454","article-title":"Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets","volume":"5","author":"Lin","year":"2004","journal-title":"AAPS PharmSciTech."},{"issue":"4","key":"10.1016\/j.ejpb.2011.02.014_b0110","first-page":"1079","article-title":"Cinnarazine orodispersible tablets: a chitosan based fast mouth dissolving technology","volume":"1","author":"Nagar","year":"2009","journal-title":"Int. J. Pharm. Tech. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2011.02.014_b0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1081\/DDC-120037665","article-title":"In vitro and ex vivo permeation studies of chlorpheniramine maleate gels prepared by carbomer derivatives","volume":"30","author":"Tas","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpharm.2009.03.023","article-title":"Studies of chitosan\/Kollicoat SR 30D film coated tablets for colonic drug delivery","volume":"375","author":"Li-Fang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10717540500313356","article-title":"Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets","volume":"13","author":"Varshosaz","year":"2006","journal-title":"Drug Deliv."},{"issue":"13","key":"10.1016\/j.ejpb.2011.02.014_b0130","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3109\/03639049409050225","article-title":"Chitin and chitosan as disintegrants in paracetamol tablets","volume":"20","author":"Ritthidej","year":"1994","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"9","key":"10.1016\/j.ejpb.2011.02.014_b0135","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1081\/DDC-200037245","article-title":"Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation","volume":"30","author":"Nafee","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2009.07.012","article-title":"Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: a study using cyclosporin A, \u03b1-cyclodextrin and quaternary chitosan N-betainate","volume":"381","author":"Mannila","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0145","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/03639040600943848","article-title":"Scopolamine sublingual spray: an alternative route of delivery for the treatment of motion sickness","volume":"33","author":"Al-Ghananeem","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","article-title":"Novel mechanisms and devices to enable successful transdermal drug delivery","volume":"14","author":"Barry","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.02.014_b0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1023\/A:1015314314796","article-title":"Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations","volume":"19","author":"Funke","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2011.02.014_b0160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejpb.2008.08.006","article-title":"Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo","volume":"72","author":"Patel","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.02.014_b0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14737175.4.1.33","article-title":"Zolmitriptan (Zomig\u00ae)","volume":"4","author":"Rapoport","year":"2004","journal-title":"Expert Rev. Neurotherapeutics"},{"key":"10.1016\/j.ejpb.2011.02.014_b0170","series-title":"Physical Pharmacy","author":"Attwood","year":"2008"},{"key":"10.1016\/j.ejpb.2011.02.014_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.04.012","article-title":"Buccal bioadhesive drug delivery\u2014a promising option for orally less efficient drugs","volume":"114","author":"Sudhakar","year":"2006","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T15:21:21Z","timestamp":1543936881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641111000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0939641111000804"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2011.02.014","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}